Our research focuses on molecular recognition for a better understanding of ligand-macromolecule interactions in order to develop new therapeutic strategies including new chemical entities and new targets, using an interdisciplinary approach based on the combination of biochemistry/biophysics and chemistry with computational chemistry/molecular modelling.